WO2025136341 - A TABLET COMPRISING BREXPIPRAZOLE
National phase entry is expected:
Publication Number
WO/2025/136341
Publication Date
26.06.2025
International Application No.
PCT/TR2024/051657
International Filing Date
20.12.2024
Title **
[English]
A TABLET COMPRISING BREXPIPRAZOLE
[French]
COMPRIMÉ COMPRENANT DU BREXPIPRAZOLE
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
ATAMAN, Seval
SARP, Onder
Priority Data
2023/018022
22.12.2023
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2100 | |
| EPO | Filing, Examination, Granting | 9157 | |
| Japan | Filing, Examination, Granting | 2153 | |
| South Korea | Filing, Examination, Granting | 2137 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,287
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a tablet comprises brexpiprazole or a salt thereof and at least one pharmaceutically acceptable excipient wherein sodium stearyl fumarate is present as lubricant. Further, the present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient process.[French]
La présente invention concerne un comprimé comprenant du brexpiprazole ou un sel de celui-ci et au moins un excipient pharmaceutiquement acceptable, le fumarate de stéaryle sodique étant présent en tant que lubrifiant. En outre, la présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique.